Neuropsychological impact of treatment of brain tumors

Cancer Treatment and Research

Volumn 150, Issue , 2009, Pages 277-296

  De Luca, Cinzia R ^a   Conroy, Rowena ^a   McCarthy, Maria C ^a   Anderson, Vicki A ^a,b   Ashley, David M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; BRAIN TUMOR; CHILD; CHRONIC BRAIN DISEASE; COGNITIVE DEFECT; FEMALE; FORECASTING; GENETICS; GROWTH DISORDER; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; RADIATION INJURY; RADIATION RESPONSE; REVIEW; SKULL IRRADIATION; SURVIVOR;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS; BRAIN DAMAGE, CHRONIC; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FORECASTING; GROWTH DISORDERS; HUMANS; MALE; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RADIATION INJURIES; SURVIVORS;

EID: 77956637446     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/b109924_17     Document Type: Article

References (117)

1. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol.2006;7:813-820. (Pubitemid 44464063)
2. Garcia-Perez A,Narbona-Garcia J, Sierrasesumaga L, Aguirre-Ventallo M, Calvo-Manuel F. Neuropsychological outcome of children after radiotherapy for intracranial tumours. DevMed Child Neurol. 1993;35:139-148. (Pubitemid 23059554)
3. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol. 2005;72:245-253. (Pubitemid 40867408)
4. Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis. Med Pediatr Oncol. 1992;20:181-191.
5. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Biol Phys.1995;31:983-998.
6. Palmer SL, Gajjar A, Reddick WE, et al. Predicting Intellectual Outcome Among Children Treated With 35- 40 Gy Craniospinal Irradiation for Medulloblastoma. Neuropsychology. 2003;17:548-555. (Pubitemid 37411874)
7. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol. 2001;19:3470-3476. (Pubitemid 32730083)
8. Moore BD. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol. 2005;30:51-63.
9. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:339-408.
10. Palmer SL, Reddick, WE, Gajjar, A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol. 2007;32:1040-1049. (Pubitemid 47622289)
11. Kieffer-Renaux V, Viguier D, Raquin M-A, et al. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer. 2005;45:814-819. (Pubitemid 41416492)
12. Spiegler BJ, Bouffet E, Greenberg ML, Rukta JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004;22:706-713. (Pubitemid 41095075)
13. Stargatt R, Rosenfeld JV, Maixner W, Ashley D. Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Dev Neuropsychol. 2007;32:729-748. (Pubitemid 47493432)
14. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol. 1998;16:1723-1728.
15. Riva D, Milani N, Pantaleoni C, Ballerini E, Giorgi C. Combined treatment modality for medulloblastoma in childhood: effects on neuropsychological functioning. Neuropediatrics. 1991;22:36-42.
16. Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E. Serial Evaluation of Academic and Behavioral Outcome After TreatmentWith Cranial Radiation in Childhood. J Clin Oncol. 2005;23:2256-2263. (Pubitemid 46218718)
17. Copeland DR, deMoor C, Moore BD, 3rd, Ater JL. Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study. J Clin Oncol. 1999;17: 3476-3486. (Pubitemid 29517918)
18. Reimers TS, Mortensen EL, Schmiegelow K. Memory deficits in long-term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions. Pediatr Blood Cancer. 2007;48:205-212. (Pubitemid 44958279)
19. Schatz J, Kramer JH, Ablin A, Matthay KK. Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology. 2000;14:189-200.
20. MulhernRK, Butler RW.Neurocognitive sequelae of childhood cancers and their treatments. Pediatr Rehabil. 2004;7:1-14. (Pubitemid 38160053)
21. Butler RW, Haser JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev. 2006;12:184-191. (Pubitemid 44646327)
22. Merchant TE, Kiehna EN, Li C-S, Xiong X, Mulhern RK. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Biol Phys. 2005;63:1546-1554. (Pubitemid 41628055)
23. Dennis M, Spiegler BJ, Hetherington CR, Greenberg ML. Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol. 1996;29:91-101. (Pubitemid 26193508)
24. Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006;24:5283-5290. (Pubitemid 46631375)
25. FouladiM,Gilger E,KocakM, et al. Intellectual and functional outcome of children 3 years old or younger who haveCNS malignancies. J Clin Oncol. 2005;23:7152-7160.
26. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol. 2004;22: 3156-3162. (Pubitemid 41103730)
27. Anderson VA, Godber T, Smibert E, Weiskop S, Ekert H. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: a longitudinal study. Br J Cancer. 2000;82:25-62.
28. Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychological effects of cranial irradiation, intrathecal methotrexate and systemic methotrexate in childhood cancer. J Clin Oncol. 1994;12:2621-2629. (Pubitemid 24379648)
29. Copeland DR, Moore BDI, Francis DJ, Jaffe N, Culbert SJ. Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. J Clin Oncol. 1996;14: 2826-2835. (Pubitemid 26329670)
30. Nathan PC, Whitcomb T, Wolters PL, et al. Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children' s Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006;47:248-504.
31. Smibert E, Anderson VA, Godber T, EkertH. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia. Br J Cancer. 1996;73:825-830. (Pubitemid 26105314)
32. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcome in young children with acute lymphoblastic leukemia treated with cranial radiation or highdose or very high-dose intravenous methotrexate. J Clin Oncol. 2006;24:3858-3864. (Pubitemid 46630732)
33. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15: 603-630.
34. Bleyer WA, Fallavollita J, Robison L, et al. Influence of age, sex and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group. Pediatr Hematol Oncol. 1990;7:329-338. (Pubitemid 20376681)
35. Waber DP, Tarbell NJ, Fairclough D, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol. 1995;13:3490-3496.
36. Campbell LK, Scaduto M, Sharp W, et al.Ameta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2007;49: 65-73. (Pubitemid 46847070)
37. Riva D, Giorgi C, Nichelli F, et al. Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology. 2002;59:48-53. (Pubitemid 34742793)
38. Anderson V, Godber T, Smibert E, Ekert H. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors. Pediatr Rehabil. 1997;1:63-76. (Pubitemid 127718499)
39. Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the PediatricOncology Group 9605 protocol. J Child Neurol. 2005;20:129-133. (Pubitemid 40484853)
40. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol. 1998;23:3-40.
41. Von Der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: ageand sex-related differences. Eur J Cancer. 2003;39:359-365. (Pubitemid 36140054)
42. Raymond-Speden E, Tripp G, Lawrence B, Holdaway D. Intellectual, Neuropsychological, and Academic Functioning in Long-Term Survivors of Leukemia. J Pediatr Psychol. 2000; 25:59-68. (Pubitemid 30112226)
43. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994; 12:627-642. (Pubitemid 24079908)
44. Buizer AI, de Sonneville LMJ, van den Heuvel-Eibrink MM, Veerman AJP. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer. 2005;45:281-290. (Pubitemid 41077161)
45. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer. 2005;44:478-486.
46. Espy KA, Moore IM, Kaufmann PM, Kramer JH, Matthay KK, Hutter JJ. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol. 2001;26:1-9. (Pubitemid 32099696)
47. Reddick WE, Glass JO, Palmer SL, et al. Atypical white matter volume development in children following craniospinal irradiation. Neuro-Oncology. 2005;7:12-19. (Pubitemid 40310189)
48. Shapiro WR, Allen JC, Horten BC. Chronic methotrexate toxicity to the central nervous system. Clin Bull. 1980;10:49-52. (Pubitemid 10013056)
49. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978-986. (Pubitemid 40349500)
50. Anderson V, Northam E, Hendy J, Wrennall J. Developmental Neuropsychology. UK: Psychology Press Ltd; 2001.
51. Gottwald B, Wilde B, Mihajlovic Z, Mehdorn HM. Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatry. 2004;75:1524-1531. (Pubitemid 39433389)
52. Steinlin M, Imfeld S, Zulauf P, et al.Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain. 2003;126:1998-2008. (Pubitemid 37059439)
53. Gottwald B, Mihajlovic Z, Wilde B, Mehdorn HM. Does the cerebellum contribute to specific aspects of attention? Neuropsychologia. 2003;41:1452-1460. (Pubitemid 36808818)
54. Stargatt R, Anderson V, Rosenfeld JV. Neuropsychological Outcome of Children Treated for Posterior Fossa Tumours: A Review. Brain Impairment. 2002;3:92-104.
55. Kao GD, Goldwein JW, Schultz DJ, Radcliffe J, Sutton L, Lange B. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors. Cancer. 1994;74: 965-971. (Pubitemid 24237482)
56. Merchant TE, Lee H, Zhu J, et al. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J Neurosurg. 2004;101:159-168. (Pubitemid 39426189)
57. Merchant TE, Kiehna EN, Miles MA, Zhu J, Xiong X, Mulhern RK. Acute effects of irradiation on cognition: changes in attention on a computerized continuous performance test during radiotherapy in pediatric patients with localized primary brain tumors. Int J Radiat Biol Phys. 2002;53:1271-1278 (Pubitemid 34787864)
58. Chapman CA, Waber DP, Bernstein JH, et al. Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors. J Child Neurol. 1995;10:209-212.
59. Packer RJ, Sposto R, Atkins TE, et al. Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. PediatrNeurosci. 1987;13:169-175.
60. Sarkar C, Pramanik P, Karak AK, et al. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol. 2002;59:49-61. (Pubitemid 34918713)
61. Armstrong CL, Stern CH, Corn BW. Memory performance used to detect radiation effects on cognitive functioning. Appl Neuropsychol. 2001;8:129-139. (Pubitemid 32976964)
62. Welzel G, Steinvorth S, Wenz F. Cognitive effects of chemotherapy and/or cranial irradiation in adults. Strahlenther Onkol. 2004;181:141-156.
63. Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159-168. (Pubitemid 38229950)
64. Armstrong CL, Gyato K, Awadalla AW, Lustig R, Tochner ZA. A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychol Rev. 2004;14:65-86. (Pubitemid 39023957)
65. Torres IJ, Mundt AJ, Sweeney PJ, et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology. 2003;60:1113-1118. (Pubitemid 36418770)
66. Laack NN, Brown PD. Cognitive sequelae of brain irradiation in adults. Semin Oncol. 2004;31:702-713. (Pubitemid 39389022)
67. Neuwelt EA, Guastadisegni PE, Varallyay P,DoolittleND. Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. AJNR. 2005; 26:258-265. (Pubitemid 43073302)
68. Fliessbach K, Urbach H, Helmstaedter C, et al. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol. 2003;60:563-568. (Pubitemid 36427970)
69. Brown PD, Buckner JC, Uhm JH, Shaw EG. The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-Oncology. 2003;5:161-167. (Pubitemid 36790345)
70. Tucha O, Smely C, Preier M, Lange K. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000;47:324-334.
71. Klein M, Heimans JJ, Aaronsen NK, et al. Effect of radiotherapy and other treatmentrelated factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. The Lancet. 2002;360:1361-1368. (Pubitemid 35341299)
72. Steen RG, Spence D, Shengjie W, Xiong X, Kun LE, Merchant TE. Effect of therapeutic ionizing radiation on the human brain. Ann Neurol. 2001;50:787-795. (Pubitemid 33116139)
73. Fletcher JM, Copeland DR. Neurobehavioural effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol. 1988;10:495-537.
74. Fouladi M, Chintagumpala M, Laningham FH, et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in childrenwith medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol. 2004;22:4551-4560. (Pubitemid 41185122)
75. Reddick WE, White HA, Glass JO, et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer. 2003;97: 2512-2519. (Pubitemid 36542491)
76. Reddick WE, Shan ZY, Glass JO, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer. 2006;106:941-949. (Pubitemid 43238463)
77. Khong PL, Leung LH, Chan GC, et al. White matter anisotropy in childhood medulloblastoma survivors: association with neurotoxicity risk factors. Radiology. 2005;236: 647-652. (Pubitemid 41023453)
78. Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884-890. (Pubitemid 46638840)
79. QiuD, LeungLH,KwongDL, ChanGC, Khong PL.Mapping radiation dose distribution on the fractional anisotropy map: applications in the assessment of treatment-induced white matter injury. Neuroimage. 2006;31:109-115. (Pubitemid 43744451)
80. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006;111:197-212.
81. Brown WR, Thore CR, Moody DM, Robbins ME, Wheeler KT. Vascular damage after fractionated whole-brain irradiation in rats. Radiat Res. 2005;164:662-668. (Pubitemid 41532562)
82. BrownWR, Blair RM, MoodyDM, et al. Capillary loss precedes the cognitive impairment induced by fractionated whole-brain irradiation: a potential rat model of vascular dementia. J Neurol Sci. 2007;257:67-71. (Pubitemid 46856486)
83. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Dis. 2006;12:174-183. (Pubitemid 44646326)
84. Rola R, Raber J, Rizk A, et al. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol. 2004;188:316-330. (Pubitemid 38891593)
85. Monje ML, Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol. 2003;16: 129-134. (Pubitemid 36521196)
86. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Biol Phys. 1999;45:137-145. (Pubitemid 29380085)
87. Mulhern RK, Palmer SL,Merchant TE, et al.Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol. 2005;23:551-559.
88. Carey ME, Hockenberry MJ, Moore IM, et al. Effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol. 2007;32:189-193.
89. Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer. 2002;95:2562-2670.
90. Storm AJ, van der Kogel AJ, Nooter K. Effect of X-irradiation on the pharmacokinetics of methotrexate in rats: alteration of the blood-brain barrier. Eur J Cancer Clin Oncol. 1985;21:759-764. (Pubitemid 15119338)
91. Lagercrantz H, Ringstedt T. Epigenetic and functional organization of the neuronal circuits in the CNS during development. In: Levene MI, Chervenak FA, Whittle M, Bennett MJ, Punt J, eds. Fetal and Neonatal Neurology and Neurosurgery. 3rd ed. London: Churchill Livingstone; 2001:3-9.
92. Huttenlocher PR.Morphometric study of human cerebral cortex development. In: Johnson MH, ed. Brain Development and Cognition. Cambridge, USA: Blackwell Publishers; 1993: 112-124.
93. Erecinska M, Cherian S, Silver IA. Energy metabolism in mammalian brain during development. Prog Neurobiol. 2004;73:392-445.
94. Giedd JN. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999;2:861-863. (Pubitemid 30602596)
95. Benes FM, Turtle M, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry. 1994;51:47-84.
96. Yakovlev PI, Lecours AR. The myelogenetic cycles of regional maturation of the brain. In: Minokowski A, ed. Regional development of the brain in early life. Philadelphia: Blackwell; 1967:3-70.
97. Brickman AM, Zimmerman ME, Paul RH, et al. Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry. 2006;60:4-53.
98. Salat DH, Tuch DS, Greve DN, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging. 2005;26:1215-1227. (Pubitemid 40726015)
99. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol. 2005;23:7152-160.
100. Hebb DO. The Organization of Behavior. New York: McGraw-Hill; 1949.
101. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis-where and how to look for it? Radiother Oncol. 2002; 64:131-140. (Pubitemid 35247890)
102. Andreassen CN, Alsner J, Overgaard J, et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol. 2005;75:18-21. (Pubitemid 40616789)
103. De Ruyck K, Wilding CS, Van Eijkeren M, Morthier R, Tawn EJ, Thierens H. Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res. 2005; 164:237-244. (Pubitemid 41233776)
104. Hall EJ, Schiff PB, Hanks GE, et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am. 1998;4:385-389.
105. Hendry JH. Genomic instability: potential contributions to tumour and normal tissue response, and second tumours, after radiotherapy. Radiother Oncol. 2001;59:117-126. (Pubitemid 32454483)
106. Butler RW, Mulhern RK. Neurocognitive Interventions for Children and Adolescents Surviving Cancer. J Pediatr Psychol.2005, 30(1): 65-78. (Pubitemid 40041442)
107. Kinsella GJ, Prior M, Sawyer M, et al. Predictors and indicators of academic outcome in children 2 years following traumatic brain injury. J Int Neuropsychol Soc. 1997;3: 608-616. (Pubitemid 27510844)
108. Taylor H. Research on outcomes of pediatric traumatic brain injury: current advances and future directions. Dev Neuropsychol. 2004;25:19-225.
109. Taylor H, Yeates KO, Wade SL, Drotar D, Klein SK, Stancin T. Influences on first-year recovery from traumatic brain injury in children. Neuropsychology. 1999;13:76-89. (Pubitemid 29066441)
110. Yeates KO, Taylor H, Drotar D, et al. Preinjury family environment as a determinant of recovery from traumatic brain injuries in school-age children. J Int Neuropsychol Soc. 1997;3:617-630. (Pubitemid 27510845)
111. Taylor H, Yeates KO, Wade SL, Drotar D, Stancin T, Burant C. Bidirectional childfamily influences on outcomes of traumatic brain injury in children. J Int Neuropsychol Soc. 2001;7:75-67.
112. Butler RW, Copeland DR. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc. 2002;8:115-124. (Pubitemid 34130479)
113. van' t Hooft I, Andersson K, Bergman B, Sejersen T, Von Wendt L, Bartfai A. Beneficial effect from a cognitive training programme on children with acquired brain injuries demonstrated in a controlled study. Brain Inj. 2005;19:51-58.
114. Anderson V, Catroppa C. Advances in postacute rehabilitation after childhoodacquired brain injury: a focus on cognitive, behavioral, and social domains. Am J Phys Med Rehabil. 2006;85:767-778. (Pubitemid 44272708)
115. Mitby PA, Robison LL, Whitton JA, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003;97:1115-1126. (Pubitemid 36173166)
116. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007:32: 1127-1139. (Pubitemid 47622295)
117. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001;19:1802-1808. (Pubitemid 32230883)